Literature DB >> 18196923

The aging cardiomyocyte: a mini-review.

D Bernhard1, G Laufer.   

Abstract

BACKGROUND: Aging per se is a risk factor for reduced cardiac function and heart diseases, even when adjusted for aging-associated cardiovascular risk factors. Accordingly, aging-related biochemical and cell-biological changes lead to pathophysiological conditions, especially reduced heart function and heart disease.
OBJECTIVE: In this review, we summarize the changes that occur as the heart ages from youth to old age on the basis of the cardiac myocyte. Aging phenotypes and underlying mechanisms shall be discussed that affect cardiomyocyte repair, signaling, structure, and function.
METHODS: Review of the literature.
RESULTS: The following factors play vital roles in the aging of cardiomyocytes: oxidative stress, inflammation, cellular protection and repair, telomere integrity, survival and death, metabolism, post-translational modifications, and altered gene expression. Importantly, non-cardiomyocyte-based aging processes (vascular, fibroblast, extracellular matrix, etc.) in the heart will interfere with cardiomyocyte aging and cardiac function.
CONCLUSION: Based on our analyses, we postulate that the physiological aging process of the heart and of the cardiomyocyte is primarily driven by intrinsic aging factors. However, extrinsic aging factors, e.g. smoking, also make an important contribution to pathologically accelerated aging of the heart. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18196923     DOI: 10.1159/000113503

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  39 in total

1.  Age-associated differences in gene expression in response to delayed anesthetic preconditioning.

Authors:  C Zhong; N Fleming; X Lu; P Moore; H Liu
Journal:  Age (Dordr)       Date:  2011-10-19

2.  In vitro aged, hiPSC-origin engineered heart tissue models with age-dependent functional deterioration to study myocardial infarction.

Authors:  Aylin Acun; Trung Dung Nguyen; Pinar Zorlutuna
Journal:  Acta Biomater       Date:  2019-05-27       Impact factor: 8.947

3.  Mechanisms and management of doxorubicin cardiotoxicity.

Authors:  Y Shi; M Moon; S Dawood; B McManus; P P Liu
Journal:  Herz       Date:  2011-06       Impact factor: 1.443

4.  Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy.

Authors:  Julie A Wolfram; Edward J Lesnefsky; Brian D Hoit; Mark A Smith; Hyoung-Gon Lee
Journal:  Ther Adv Chronic Dis       Date:  2011-03-01       Impact factor: 5.091

5.  Relation of cardiovascular risk factors to right ventricular structure and function as determined by magnetic resonance imaging (results from the multi-ethnic study of atherosclerosis).

Authors:  Harjit Chahal; Craig Johnson; Harikrishna Tandri; Aditya Jain; W Gregory Hundley; R Graham Barr; Steven M Kawut; Joao A C Lima; David A Bluemke
Journal:  Am J Cardiol       Date:  2010-05-13       Impact factor: 2.778

6.  Quantification of protein expression changes in the aging left ventricle of Rattus norvegicus.

Authors:  Jennifer E Grant; Amy D Bradshaw; John H Schwacke; Catalin F Baicu; Michael R Zile; Kevin L Schey
Journal:  J Proteome Res       Date:  2009-09       Impact factor: 4.466

Review 7.  Effect of aging on cellular mechanotransduction.

Authors:  Miaozong Wu; Jacqueline Fannin; Kevin M Rice; Bin Wang; Eric R Blough
Journal:  Ageing Res Rev       Date:  2009-11-20       Impact factor: 10.895

8.  Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.

Authors:  R Jung; M W Wendeler; M Danevad; H Himmelbauer; R Gessner
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 9.  Cardiomyocyte death in doxorubicin-induced cardiotoxicity.

Authors:  Yi-Wei Zhang; Jianjian Shi; Yuan-Jian Li; Lei Wei
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2009-10-29       Impact factor: 4.291

10.  Innate regeneration in the aging heart: healing from within.

Authors:  Piero Anversa; Annarosa Leri
Journal:  Mayo Clin Proc       Date:  2013-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.